Population studies have clearly established a link between insulin and IGF-I levels and the risk and prognosis of certain cancers, with much of this research driven by the rapidly growing incidence of obesity and metabolic syndrome across the globe (1–5). The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.